Delivery Order SPE2DB20D1109-SPE2DB25FP53Q
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,306.43 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Testosterone Cypionate 200 mg/ml. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.36 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,076.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain...
- The Defense Logistics Agency awarded a delivery order valued at $1,619.00 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, competitively awarded delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. AmerisourceBergen will perform this contract from its corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $1,713.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This competitively awarded, non-set-aside contract features firm fixed pricing and a delivery completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.04 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, a hormone replacement therapy medication. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-competed award under the company's existing contract vehicle. Performance will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.86 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,761.52 on July 22, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The award represents a single-item pharmaceutical procurement supporting military healthcare supply...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP53QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major healthcare solutions provider and pharmaceutical distributor. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare programs and other federal medical systems worldwide. The company's extensive portfolio of federal medical procurement contracts demonstrates its established capability to meet Defense Logistics Agency requirements across multiple therapeutic domains and delivery scenarios.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/7/25 |